Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 4,162 |
|
|||||
| News | - | ||||||
| Day High | 3.325 | Low High |
|||||
| Day Low | 3.1931 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lixte Biotechnology Holdings Inc | LIXT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 1.24% | 3.26 | 23:00:16 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.26 | 3.1931 | 3.325 | 3.26 | 3.22 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 59 | 4,162 | US$ 3.27 | US$ 13,603 | - | 1.58 - 9.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:55:06 | 2 | US$ 3.35 | USD |
Lixte Biotechnology Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.33M | 2.25M | - | 0 | -5.09M | -2.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lixte Biotechnology News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/24/2024 | 14:25 | AllPennyStocks.com | Mixed Shelf Filing Gives Micro Cap Delayed Boost |
| 3/27/2024 | 14:35 | AllPennyStocks.com | Biotech Steals The Show Following Pre-Clinical Data.. |
| 3/27/2024 | 07:30 | GlobeNewswire Inc. | NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD.. |
| 3/21/2024 | 07:30 | GlobeNewswire Inc. | LIXTE Provides Update on Progress with LB-100 as a PP2A.. |
| 2/27/2024 | 15:59 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/27/2024 | 07:30 | GlobeNewswire Inc. | Professor René Bernards to Present New Pre-Clinical Data on.. |
| 2/26/2024 | 09:48 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/26/2024 | 07:30 | GlobeNewswire Inc. | LIXTE Biotechnology Enters into Exclusive Immune Oncology.. |
| 1/29/2024 | 07:30 | GlobeNewswire Inc. | First Patient Dosed with LIXTE’s LB-100 and GSK’s.. |
| 11/28/2023 | 16:21 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 13:28 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 07:30 | GlobeNewswire Inc. | LIXTE Biotechnology Provides Update on Clinical Progress and.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LIXT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.45 | 3.59 | 3.1048 | 3.28 | 20,698 | -0.19 | -5.51% |
| 1 Month | 3.27 | 3.87 | 2.9001 | 3.43 | 77,969 | -0.01 | -0.31% |
| 3 Months | 2.06 | 4.40 | 1.90 | 3.44 | 609,370 | 1.20 | 58.25% |
| 6 Months | 2.16 | 4.42 | 1.69 | 3.40 | 305,888 | 1.10 | 50.93% |
| 1 Year | 6.10 | 9.50 | 1.58 | 3.94 | 200,612 | -2.84 | -46.56% |
| 3 Years | 25.30 | 49.50 | 1.58 | 17.69 | 732,617 | -22.04 | -87.11% |
| 5 Years | 38.50 | 71.90 | 1.58 | 21.68 | 731,376 | -35.24 | -91.53% |
Lixte Biotechnology Description
| Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect on altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors. |
